Psyence Group Inc. (CSE:PSYG)

Canada flag Canada · Delayed Price · Currency is CAD
0.120
+0.010 (9.09%)
Nov 20, 2025, 10:10 AM EST
-60.00%
Market Cap 1.88M
Revenue (ttm) n/a
Net Income (ttm) -16.37M
Shares Out 15.64M
EPS (ttm) -1.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,000
Average Volume 4,653
Open 0.120
Previous Close 0.110
Day's Range 0.120 - 0.120
52-Week Range 0.105 - 0.375
Beta 1.24
RSI 44.76
Earnings Date Nov 28, 2025

About Psyence Group

Psyence Group Inc., a life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma. It operates in two segments, Clinical Trial Activities and Non-Clinical Trial Activities. The company develops botanical psilocybin-based psychedelic medicine, which works with natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. It also focuses on the research and development, c... [Read more]

Sector Healthcare
Founded 2019
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol PSYG
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.